These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 28182816)

  • 1. A 13-Year Single Institutional Experience with Definitive Radiotherapy in Hypopharyngeal Cancer.
    Sommat K; Yong SK; Fong KW; Tan TW; Wee JT; Soong YL
    Ann Acad Med Singap; 2017 Jan; 46(1):32-36. PubMed ID: 28182816
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
    Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
    Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx.
    Daly ME; Le QT; Jain AK; Maxim PG; Hsu A; Loo BW; Kaplan MJ; Fischbein NJ; Colevas AD; Pinto H; Chang DT
    Head Neck; 2011 Jan; 33(1):103-11. PubMed ID: 20848427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy modality as a predictor of survival in hypopharyngeal cancer.
    Kılıç S; Kılıç SS; Hsueh WD; Eloy JA; Baredes S; Woo Park RC; Mahmoud O
    Head Neck; 2018 Nov; 40(11):2441-2448. PubMed ID: 30306665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous cell carcinoma of the hypopharynx: single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches.
    Gupta T; Chopra S; Agarwal JP; Laskar SG; D'cruz AK; Shrivastava SK; Dinshaw KA
    Acta Oncol; 2009; 48(4):541-48. PubMed ID: 18979267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.
    Kuo P; Sosa JA; Burtness BA; Husain ZA; Mehra S; Roman SA; Yarbrough WG; Judson BL
    Cancer; 2016 Jun; 122(12):1853-60. PubMed ID: 27019213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracking of hypopharyngeal carcinoma over 10 years.
    Kojima K; Suzuki K; Ito Y; Moribe K; Kimura T; Tsuge I; Koketsu M; Itaya T; Motai H; Baba S
    Acta Otolaryngol Suppl; 1996; 525():146-50. PubMed ID: 8908290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer.
    Lee MS; Ho HC; Hsiao SH; Hwang JH; Lee CC; Hung SK
    Acta Otolaryngol; 2008 Jan; 128(1):103-9. PubMed ID: 17851955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx.
    Kraus DH; Zelefsky MJ; Brock HA; Huo J; Harrison LB; Shah JP
    Otolaryngol Head Neck Surg; 1997 Jun; 116(6 Pt 1):637-41. PubMed ID: 9215375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
    Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
    Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Single Institution's Experience of Definitive Radiotherapy Using Volumetric-modulated Arc Therapy for Hypopharyngeal Cancers.
    Kubo K; Murakami Y; Imano N; Takeuchi Y; Nishibuchi I; Kimura T; Kawahara D; Miki K; Saito A; Nakashima T; Hamamoto T; Ueda T; Takeno S; Nagata Y
    Anticancer Res; 2020 Jul; 40(7):4183-4190. PubMed ID: 32620668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of total tumor volume in advanced-stage laryngeal and hypopharyngeal carcinoma.
    Yang CJ; Kim DY; Lee JH; Roh JL; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2013 Dec; 108(8):509-15. PubMed ID: 24590673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of postoperative simultaneous modulated accelerated radiotherapy for head-and-neck squamous cell carcinoma.
    Moon SH; Jung YS; Ryu JS; Choi SW; Park JY; Yun T; Lee SH; Cho KH
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):140-9. PubMed ID: 20732767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma.
    He Y; Zhou Q; Shen L; Zhao Y; Lei M; Wei R; Shen L; Cao S
    Radiat Oncol; 2015 Apr; 10():89. PubMed ID: 25881159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
    Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it necessary to dissect levels I and IIB in hypopharyngeal cancer?
    Wiegand S; Esters J; Müller HH; Jäcker T; Roessler M; Werner JA; Sesterhenn AM
    Acta Otolaryngol; 2010 Jun; 130(6):747-52. PubMed ID: 19968609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
    Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
    Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of posterior hypopharyngeal wall squamous cell carcinoma: a report of 36 cases].
    Wang JH; Qi YF; Tang PZ; Wen SX; Zhang ZM; Qin DX
    Ai Zheng; 2005 Sep; 24(9):1106-10. PubMed ID: 16159434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognoses and long-term outcomes of nasopharyngeal carcinoma in Han and Uyghur patients treated with intensity-modulated radiotherapy in the Xinjiang Autonomous Region of China.
    Wang R; Tan Y; Wang X; Ma L; Wang D; Hu Y; Qin Y; Liu K; Chang C; Yu J
    PLoS One; 2014; 9(11):e111145. PubMed ID: 25375129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
    Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
    Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.